Insider Trading Activity Clearside Biomedical Inc (NASDAQ:CLSD) – Director Bought 7,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For Clearside Biomedical Inc (NASDAQ:CLSD)

Gerald D Cagle , Director of Clearside Biomedical Inc (NASDAQ:CLSD) reportedly Bought 7,500 shares of the company’s stock at an average price of 11.89 for a total transaction amount of $89,175.00 SEC Form

Insider Trading History For Clearside Biomedical Inc (NASDAQ:CLSD)

  • On 6/7/2016 Venture Advisors Iv S Hatteras, Major Shareholder, bought 414,286 with an average share price of $7.00 per share and the total transaction amounting to $2,900,002.00.
  • On 6/7/2016 Clay Thorp, Director, sold 138 with an average share price of $7.00 per share and the total transaction amounting to $966.00.
  • On 1/19/2017 Venture Advisors Iii Hatteras, Insider, sold 25,301 with an average share price of $8.63 per share and the total transaction amounting to $218,347.63.
  • On 1/20/2017 Clay Thorp, Director, sold 68,485 with an average share price of $8.53 per share and the total transaction amounting to $584,177.05.
  • On 2/17/2017 Clay Thorp, Director, sold 41,485 with an average share price of $7.60 per share and the total transaction amounting to $315,286.00.
  • On 2/22/2017 Clay Thorp, Director, sold 27,000 with an average share price of $7.55 per share and the total transaction amounting to $203,850.00.
  • On 3/16/2017 Clay Thorp, Director, sold 68,485 with an average share price of $6.56 per share and the total transaction amounting to $449,261.60.

    • Analyst Ratings History For Clearside Biomedical Inc (NASDAQ:CLSD)

    • On 10/24/2016 Stifel Nicolaus Boost Price Target of rating Buy with a price target of $13.00 to $23.00
    • On 10/25/2017 Cowen Reiterated Rating Buy
    • On 3/5/2018 JMP Securities Reiterated Rating Outperform with a price target of $25.00
    • On 3/6/2018 JPMorgan Chase & Co. Reiterated Rating Overweight to Overweight with a price target of $15.00 to $18.00
    • On 3/6/2018 Needham & Company LLC Boost Price Target of rating Buy to Buy with a price target of $18.00 to $22.00
    • On 3/20/2018 Wedbush Reiterated Rating Outperform with a price target of $29.00

    Recent Trading Activity for Clearside Biomedical Inc (NASDAQ:CLSD)
    Shares of Clearside Biomedical Inc closed the previous trading session at 11.88 up +0.16 1.37% with 257487 shares trading hands.